Skip to content

GYNEMED

Active
Private limited companyfounded 1996active for 30 yearsWinston Churchilllaan 62, 1180 Ukkel, BelgiumKBO/BCE: BE 0457.846.730
Summary

GYNEMED has been active since 1996 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€21,978) and a net result of -€4,848. Equity is shrinking by about 40% per year across the filed financial years. The computed 12-month bankruptcy probability is 1.3% (low).

History

On 19 April 1996, GYNEMED was incorporated.1 Turnover went from €9,969 in 2019 to €1,002 in 2025.2

  1. 1KBO register
  2. 2National Bank, annual accounts 2019 and 2025

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 31-01-2027
2026
27-01
NBB filing Annual accounts filed
financial year 2025 · full format
2024
23-12
NBB filing Annual accounts filed
financial year 2024 · full format
2023
15-12
NBB filing Annual accounts filed
financial year 2023 · full format
2022
16-12
NBB filing Annual accounts filed
financial year 2022 · full format
14-01
NBB filing Annual accounts filed
financial year 2021 · full format
2021
14-01
NBB filing Annual accounts filed
financial year 2020 · full format
2020
30-06
Financial Weakest financial yearnet -€20,794
Net result drops to -€20,794, the lowest in the series; recovery starts the following year.
2019
30-12
NBB filing Annual accounts filed
financial year 2019 · full format
2018
26-12
NBB filing Annual accounts filed
financial year 2018 · full format
2017
19-12
NBB filing Annual accounts filed
financial year 2017 · full format
24-01
NBB filing Annual accounts filed
financial year 2016 · full format
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 29 annual accounts filed, the latest 10 are here; all 29 are under Financials.
0 of 4 deeds read
About the unread acts

We know of 4 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.